Furthermore, inflammatory factors sICAM-1, MCP1, and Pentraxin 3 (PTX3) are increased in the vitreous of patients with diabetic macular edema (DME) (5), and steroids remain an effective alternative treatment to anti-VEGFs (6). Here, PTX3 is linked to diabetic macular edema.